178 related articles for article (PubMed ID: 32946175)
1. Modulation of co-stimulatory signal from CD2-CD58 proteins by a grafted peptide.
Parajuli P; Sable R; Shrestha L; Dahal A; Gauthier T; Taneja V; Jois S
Chem Biol Drug Des; 2021 Mar; 97(3):607-627. PubMed ID: 32946175
[TBL] [Abstract][Full Text] [Related]
2. Constrained Cyclic Peptides as Immunomodulatory Inhibitors of the CD2:CD58 Protein-Protein Interaction.
Sable R; Durek T; Taneja V; Craik DJ; Pallerla S; Gauthier T; Jois S
ACS Chem Biol; 2016 Aug; 11(8):2366-74. PubMed ID: 27337048
[TBL] [Abstract][Full Text] [Related]
3. Immunosuppression by co-stimulatory molecules: inhibition of CD2-CD48/CD58 interaction by peptides from CD2 to suppress progression of collagen-induced arthritis in mice.
Gokhale A; Kanthala S; Latendresse J; Taneja V; Satyanarayanajois S
Chem Biol Drug Des; 2013 Jul; 82(1):106-18. PubMed ID: 23530775
[TBL] [Abstract][Full Text] [Related]
4. Targeting protein-protein interaction for immunomodulation: A sunflower trypsin inhibitor analog peptidomimetic suppresses RA progression in CIA model.
Dahal A; Parajuli P; Singh SS; Shrestha L; Sonju JJ; Shrestha P; Chatzistamou I; Jois S
J Pharmacol Sci; 2022 Jul; 149(3):124-138. PubMed ID: 35641025
[TBL] [Abstract][Full Text] [Related]
5. A peptide from the beta-strand region of CD2 protein that inhibits cell adhesion and suppresses arthritis in a mouse model.
Satyanarayanajois SD; Büyüktimkin B; Gokhale A; Ronald S; Siahaan TJ; Latendresse JR
Chem Biol Drug Des; 2010 Sep; 76(3):234-44. PubMed ID: 20572813
[TBL] [Abstract][Full Text] [Related]
6. Investigating cyclic peptides inhibiting CD2-CD58 interactions through molecular dynamics and molecular docking methods.
Leherte L; Petit A; Jacquemin D; Vercauteren DP; Laurent AD
J Comput Aided Mol Des; 2018 Nov; 32(11):1295-1313. PubMed ID: 30368623
[TBL] [Abstract][Full Text] [Related]
7. Conformationally constrained peptides from CD2 to modulate protein-protein interactions between CD2 and CD58.
Gokhale A; Weldeghiorghis TK; Taneja V; Satyanarayanajois SD
J Med Chem; 2011 Aug; 54(15):5307-19. PubMed ID: 21755948
[TBL] [Abstract][Full Text] [Related]
8. The contribution of conformational adjustments and long-range electrostatic forces to the CD2/CD58 interaction.
Kearney A; Avramovic A; Castro MA; Carmo AM; Davis SJ; van der Merwe PA
J Biol Chem; 2007 May; 282(18):13160-6. PubMed ID: 17344209
[TBL] [Abstract][Full Text] [Related]
9. Structure-based identification of inhibitors disrupting the CD2-CD58 interactions.
Tripathi N; Leherte L; Vercauteren DP; Laurent AD
J Comput Aided Mol Des; 2021 Mar; 35(3):337-353. PubMed ID: 33532888
[TBL] [Abstract][Full Text] [Related]
10. Impact of salt bridges on the equilibrium binding and adhesion of human CD2 and CD58.
Bayas MV; Kearney A; Avramovic A; van der Merwe PA; Leckband DE
J Biol Chem; 2007 Feb; 282(8):5589-96. PubMed ID: 17172599
[TBL] [Abstract][Full Text] [Related]
11. Costimulatory Function of Cd58/Cd2 Interaction in Adaptive Humoral Immunity in a Zebrafish Model.
Shao T; Shi W; Zheng JY; Xu XX; Lin AF; Xiang LX; Shao JZ
Front Immunol; 2018; 9():1204. PubMed ID: 29904386
[TBL] [Abstract][Full Text] [Related]
12. Structural biology of the cell adhesion protein CD2: from molecular recognition to protein folding and design.
Wilkins AL; Yang W; Yang JJ
Curr Protein Pept Sci; 2003 Oct; 4(5):367-73. PubMed ID: 14529530
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-A resolution.
Ikemizu S; Sparks LM; van der Merwe PA; Harlos K; Stuart DI; Jones EY; Davis SJ
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4289-94. PubMed ID: 10200255
[TBL] [Abstract][Full Text] [Related]
14. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors.
Wang JH; Smolyar A; Tan K; Liu JH; Kim M; Sun ZY; Wagner G; Reinherz EL
Cell; 1999 Jun; 97(6):791-803. PubMed ID: 10380930
[TBL] [Abstract][Full Text] [Related]
15. Adhesive bond dynamics in contacts between T lymphocytes and glass-supported planar bilayers reconstituted with the immunoglobulin-related adhesion molecule CD58.
Dustin ML
J Biol Chem; 1997 Jun; 272(25):15782-8. PubMed ID: 9188475
[TBL] [Abstract][Full Text] [Related]
16. A model for CD2/CD58-mediated adhesion strengthening.
Shao JY; Yu Y; Dustin ML
Ann Biomed Eng; 2005 Apr; 33(4):483-93. PubMed ID: 15909654
[TBL] [Abstract][Full Text] [Related]
17. Interaction between human CD2 and CD58 involves the major beta sheet surface of each of their respective adhesion domains.
Arulanandam AR; Kister A; McGregor MJ; Wyss DF; Wagner G; Reinherz EL
J Exp Med; 1994 Nov; 180(5):1861-71. PubMed ID: 7525842
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity studies of peptides from the "hot-spot" region of human CD2 protein: development of peptides for immunomodulation.
Liu J; Ying J; Chow VT; Hruby VJ; Satyanarayanajois SD
J Med Chem; 2005 Oct; 48(20):6236-49. PubMed ID: 16190751
[TBL] [Abstract][Full Text] [Related]
19. Design, structure and biological activity of beta-turn peptides of CD2 protein for inhibition of T-cell adhesion.
Jining L; Makagiansar I; Yusuf-Makagiansar H; Chow VT; Siahaan TJ; Jois SD
Eur J Biochem; 2004 Jul; 271(14):2873-86. PubMed ID: 15233784
[TBL] [Abstract][Full Text] [Related]
20. MHC class II ligation induces CD58 (LFA-3)-mediated adhesion in human T cells.
Nielsen M; Gerwien J; Geisler C; Röpke C; Svejgaard A; Odum N
Exp Clin Immunogenet; 1998; 15(2):61-8. PubMed ID: 9691200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
